Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Baylor College of Medicine
Avacta Life Sciences Ltd
Jonsson Comprehensive Cancer Center
Poseida Therapeutics, Inc.
National Cancer Institute (NCI)
University of Chicago
Canadian Cancer Trials Group
Fox Chase Cancer Center
Xencor, Inc.
Roswell Park Cancer Institute
MacroGenics
Ohio State University Comprehensive Cancer Center
University Health Network, Toronto
Dana-Farber Cancer Institute
SWOG Cancer Research Network
University of Arizona
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Washington
Duke University
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
European Organisation for Research and Treatment of Cancer - EORTC
NYU Langone Health
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center